Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_assertion type Assertion NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_head.
- NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_assertion description "[Importantly, however, SUZ12 inactivation also triggers an epigenetic switch that sensitizes these cancers to bromodomain inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_provenance.
- NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_assertion evidence source_evidence_literature NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_provenance.
- NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_assertion SIO_000772 25119042 NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_provenance.
- NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_assertion wasDerivedFrom befree-20150227 NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_provenance.
- NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_assertion wasGeneratedBy ECO_0000203 NP874017.RA4dPHVyWVFiSfbuGMXL6ld4pkdCTuoSNcrtVMuG5R5Y4130_provenance.